Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2026-01-01 @ 10:08 PM
Study NCT ID:
NCT06630403
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2024-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis
Sponsor:
Atlas University
Organization:
Study Overview
Official Title:
Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.
Detailed Description:
The main causes affecting exercise capacity in patients with bronchiectasis are restriction of tidal expiratory flow, dyspnea secondary to dynamic hyperinflation, changes in pulmonary mechanics, inadequate gas exchange and decreased skeletal muscle mass. Due to all these symptoms, exercise capacity decreases in patients with bronchiectasis and the importance of physical activity increases. . In addition to decreased exercise capacity in individuals with bronchiectasis, studies on the effect of motor imagery ability, which is considered as a mental exercise, have not been found. Inadequate blood supply to the brain and muscle dysfunction have been reported to cause cognitive damage and decreased reaction time in COPD patients.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: